Modern Chinese Medicine Group (01643) announced profits, expecting a mid-term net profit attributable to shareholders of not less than 2 million yuan, a turnaround from a loss in the same period last year.

Financial news from the Wise Finance APP, Modern Traditional Chinese Medicine Group (01643) announced that the group is expected to achieve a profit of not less than 20 million yuan attributable to equity holders for the six months ending on June 30, 2025, while in the six months ending on June 30, 2024, a loss of approximately 6.9 million yuan was incurred. The board of directors believes that the turnaround from loss to profit is mainly due to a significant reduction in losses from the disposal of properties, factories, and equipment. In the six months ending on June 30, 2024, the group incurred a huge loss from the disposal of properties, factories, and equipment due to the dismantling of the formulation workshop.